Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Gallacher

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Pharmacoeconomics|December 9, 1995
Formulary management of drugs for cancer-associated hypercalcaemiaS J Gallacher
Current Opinion in Rheumatology|May 1, 1993
Paget's disease of boneS J Gallacher
Calcified Tissue International|September 28, 2010
Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic reviewS J Gallacher, T Dixon
Scottish Medical Journal|December 20, 2011
Using WHO-FRAX to describe fracture risk: experience in primary careF R MacLean, S A Thomson, S J Gallacher
Scottish Medical Journal|April 1, 1991
Pseudogout associated with the use of cyclical etidronate therapyS J Gallacher, I T Boyle, H A Capell
Injury|July 30, 2005
Osteoporosis risk assessment and treatment intervention after hip or shoulder fracture. A comparison of two centres in the United KingdomA W Murray, C McQuillan, B Kennon, et al.
BMJ (Clinical Research Ed.)|July 15, 1989
Hypercalcaemia in malignancyS H Ralston, S J Gallacher, U Parel, et al.
Nuclear Medicine Communications|November 1, 1990
Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatmentU Patel, S J Gallacher, I T Boyle, et al.
Lancet (London, England)|April 9, 1994
Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthmaS J Gallacher, K Anderson, S W Banham, et al.
Scottish Medical Journal|October 1, 1989
The hyperthyroidism of polyostotic fibrous dysplasia--a possible autoimmune aetiologyS J Gallacher, R Wilson, I T Boyle, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Pharmacoeconomics|December 9, 1995
Formulary management of drugs for cancer-associated hypercalcaemiaS J Gallacher
Current Opinion in Rheumatology|May 1, 1993
Paget's disease of boneS J Gallacher
Calcified Tissue International|September 28, 2010
Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic reviewS J Gallacher, T Dixon
Scottish Medical Journal|December 20, 2011
Using WHO-FRAX to describe fracture risk: experience in primary careF R MacLean, S A Thomson, S J Gallacher
Scottish Medical Journal|April 1, 1991
Pseudogout associated with the use of cyclical etidronate therapyS J Gallacher, I T Boyle, H A Capell
Injury|July 30, 2005
Osteoporosis risk assessment and treatment intervention after hip or shoulder fracture. A comparison of two centres in the United KingdomA W Murray, C McQuillan, B Kennon, et al.
BMJ (Clinical Research Ed.)|July 15, 1989
Hypercalcaemia in malignancyS H Ralston, S J Gallacher, U Parel, et al.
Nuclear Medicine Communications|November 1, 1990
Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatmentU Patel, S J Gallacher, I T Boyle, et al.
Lancet (London, England)|April 9, 1994
Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthmaS J Gallacher, K Anderson, S W Banham, et al.
Scottish Medical Journal|October 1, 1989
The hyperthyroidism of polyostotic fibrous dysplasia--a possible autoimmune aetiologyS J Gallacher, R Wilson, I T Boyle, et al.
Pageof 5